Medical Enzymes and Nektar Therapeutics announce PEGylation cooperation
26-Sep-2006 -
Medical Enzymes AG announced the signing of a license agreement with Nektar Therapeutics to use Nektar's proprietary PEGylation for Medical Enzymes' lead product GlutaDON®. GlutaDON® is currently in clinical development for the treatment of different solid tumours.
Under the terms of the ...
license agreements
milestone payments
PEGylation